Learn About the Quiz
View Product Details
Myriad Customer Service
Decrease costs while improving patient well-being
Learn More »
Accurate test results drive optimal treatments
If you are a payer or insurance provider, please contact us to receive more information.
EVP, Corporate Communications
VP, Investor Relations
800 4-MYRIAD (800 469-7423)
Myriad Genetics, Inc.
320 Wakara Way
Salt Lake City, UT 84108
At Myriad, our passion for patients drives everything we do – on the job and in the community.
Myriad is answering patients’ most pressing questions about disease.
Myriad has the deepest diagnostic pipeline across the disease spectrum.
At Myriad, we’re leveraging our unique expertise in sequencing and analysis to better understand human disease.
The Myriad myRisk Hereditary Cancer test is a 35-gene panel that identifies an elevated risk for eight hereditary cancers.
GeneSight meets a significant unmet clinical need and is the leading product for psychotropic drug selection.
The Myriad Foresight Carrier Screen is systematically designed to maximize the detection of at-risk couples for a pregnancy affected by inherited conditions.
Apr 17, 2019
Apr 09, 2019
Colon cancer is the second-leading cause of cancer death in the United States. According to the American Cancer Society, one in
Myriad Genetics Second Quarter Fiscal 2019 Financial Results Conference Call
February 5, 2019
4:30 PM ET